These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 19768732)
1. Müller cell-derived VEGF is a significant contributor to retinal neovascularization. Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732 [TBL] [Abstract][Full Text] [Related]
2. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome. Stalmans I Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858 [TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth. Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397 [TBL] [Abstract][Full Text] [Related]
6. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells. Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191 [TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. Zhang SX; Wang JJ; Gao G; Parke K; Ma JX J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of retinal neovascularization by siRNA targeting VEGF(165). Xia XB; Xiong SQ; Song WT; Luo J; Wang YK; Zhou RR Mol Vis; 2008; 14():1965-73. PubMed ID: 18978955 [TBL] [Abstract][Full Text] [Related]
9. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858 [TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eye. Ash J; McLeod DS; Lutty GA Mol Vis; 2005 Apr; 11():298-308. PubMed ID: 15889014 [TBL] [Abstract][Full Text] [Related]
14. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462 [TBL] [Abstract][Full Text] [Related]
15. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice. Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization. Zhang M; Yang Y; Yan M; Zhang J Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337 [TBL] [Abstract][Full Text] [Related]
18. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits. Alikacem N; Yoshizawa T; Nelson KD; Wilson CA Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677 [TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions. Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061 [TBL] [Abstract][Full Text] [Related]
20. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]